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Ser 51 in the NH,-terminal sequence of the a-subunit of eukaryotic peptide initiation factor 2 (eIF-2) has 
been identified as a second phosphorylation site for the heme-controlled eIF-2a kinase from rabbit reticulo- 
cytes. Increased phosphorylation of this serine relative to the previously described phosphorylation site (Ser 
48) is observed when the kinase reaction is carried out in the presence of the u-subunit of spectrin. A synthet- 
ic peptide corresponding to eIF-2a(41-54) is phosphorylated only in Ser 51 by the eIF-2a kinase. 
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1. INTRODUCTION 
The importance of eIF-2ru phosphorylation for 
translational control in mammalian reticulocytes 
and other cells has been reviewed (cf. [ 11). Recently 
we determined the NHz-terminal amino acid se- 
quence of HPLC-purified eIF-2cr through Arg 52 
to be: Pro-Gly-Leu-Ser-X-Arg-Phe-Tyr-Gln-Ser- 
Lys-Phe-Pro-Glu-Val-Gln-Asp-Val-Val-Met-Val- 
Asn-Met-Arg-Ser-Ile-Ala-Glu-Met-Gly-Ala-Tyr- 
Val-Ser-Leu-Leu-Glu-Tyr-Asn-Asn-Ile-Glu-Gly- 
(Arg)-Ile-Leu-Leu-Serds-Glu-Leu-Sersl-Arg PI. 
The major phosphorylation sites for the 
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reticulocyte heme-controlled kinase were recovered 
in the tryptic derivative corresponding to 
eIF-2cu(45-52) [2] containing two possible serine 
phosphorylation sites. Ser 48 was identified as a 
phosphorylation site by chymotryptic subdigestion 
of both whole eIF-2cu and a tryptic fragment term- 
ed the T-44 peptide. In these experiments Ser 51 
could not be unequivocally excluded as a second 
phosphorylation site. Here we show that Ser 51 of 
eIF-2Eu can be phosphorylated by the eIF-ti kinase 
and that the extent of Ser 51 phosphorylation is 
greater in the presence of a spectrin subunit pep- 
tide. This serine residue was found to be the 
primary phosphorylation site in a synthetic peptide 
analog of eIF-2ru corresponding to the sequence 
eIF-2ru(41-54). The two additional arginine 
residues at positions 53 and 54 were deduced from 
the rat and human cDNA sequences [3]. 
2. MATERIALS AND METHODS 
Abbreviations: eIF-2cy, a-subunit of eukaryotic initia- 2.1. Synthesis of a peptide analog of eIF-2cu 
tion factor 2; HPLC, high-performance liquid The peptide Ile-Glu-Gly-Arg-Ile-Leu-Leu-Ser- 
chromatography; TFA, trifluoroacetic acid Glu-Leu-Ser-Arg-Arg-Arg corresponding to 
16 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/87/$3.50 0 1987 Federation of European Biochemical Societies 
Volume 215, number 1 FEBS LETTERS May 1987 
eIF-ti(41-54) [2,3] was synthesized as the COOH- 
terminal amide using the Merrifield procedure [4] 
on an Applied Biosystems 430A peptide syn- 
thesizer. Purification by chromatography on an 
Amicon Cis reversed-phase column (250 A pore 
size) was carried out, using the elution conditions 
in [5]. 
2.2. Phosphorylation of eIF-2 and isolation of 
phosphorylated eIF-2cu 
Preparation of eIF-2 from the 0.5 M salt wash 
fraction of rabbit reticulocytes has been described 
[6]. The reticulocyte heme-regulated eIF-2cu kinase 
was purified through the preparative gel elec- 
trophoresis step [7]. Spectrin was isolated from a 
washed rabbit reticulocyte membrane fraction by 
the method of Litman et al. [8] then chroma- 
tographed on calmodulin-Sepharose (Sigma, St. 
Louis, MO) to separate its u- and @subunits 191. 
Phosphorylation of eIF-2 was carried out as de- 
scribed [7]. For the experiment described below, 
about 0.8 mg eIF-2 was phosphorylated for 20 min 
at 35°C in a total volume of 0.5 ml with 40rg 
eIF-2cu kinase, 150 ,ug cu-spectrin and 0.1 mM [y- 
32P]ATP (3 Ci/mmol). After incubation an equal 
volume of 6 M guanidine-HCl, 2 mM EDTA and 
1% (v/v) TFA was added and the sample loaded 
onto a wide-pore 0.46 x 25 cm CS HPLC column 
(Bakerbond, J.T. Baker) fitted with a Brownlee 
RP 300 C8 guard column. The column was washed 
with 0.1% TFA before proteins were eluted with 
an acetonitrile gradient. The details of the 
reversed-phase HPLC, including the elution posi- 
tion of phosphorylated and unphosphorylated 
eIF-2cu, have been reported [2]. 
2.3. Phosphorylation of the synthetic peptide 
The synthetic eIF-2cu(41-54) peptide (7 1 pg) was 
phosphorylated with 21 pug eIF-2cu kinase and 
0.25 mM [Y-~~P]ATP (0.7 Ci/mmol) for 3.5 h at 
35°C in a total volume of 300 pl. The reaction mix- 
ture was adjusted to contain 1% TFA and 1 mM 
EDTA, then the peptide was reisolated by HPLC 
as described above for eIF-h. 
For K,,, determination reaction mixtures were in- 
cubated in a total volume of 30~1 for 30 min at 
35°C (the reaction rate was constant for at least 
2 h) containing 0.12 pg eIF-h kinase and 
substrate concentrations from 16 to 266,uM with 
0.25 mM [y-32P]ATP (about 0.2 Ci/mmol). Reac- 
tions were terminated by adding acetic acid to give 
30%. Aliquots of 40 ~1 were pipetted onto What- 
man P81 paper squares and their radioactivity 
determined as described [ 101. 
2.4. Protease digestion and separation of 
phosphopeptides 
Conditions for trypsin digestion of eIF-2cu have 
been reported previously [2]. Incubation with tryp- 
sin was done for 20 min at 35°C after which time 
the sample was made 3 M in guanidine-HCl, 1 mM 
in EDTA and 1% in TFA and loaded and 
chromatographed on the Cs Bakerbond column. 
The isolated tryptic phosphopeptides or the 
phosphorylated synthetic eIF-ti(41-54) were 
digested further with Staphylococcus aureus VS 
protease (Sigma). 
Incubation was carried out in a total volume of 
100~1 of 0.1 M NI%HCO3, pH 7.8, containing 
0.5-1.5 nmol phosphopeptide and 2pg VS pro- 
tease at 35°C for the times indicated in the figure 
legends. V8 incubation mixtures were made 1% in 
TFA and 1 mM in EDTA and loaded on the CS 
HPLC column equilibrated and then developed as 
described above. Fractions of 1 ml were collected 
and their radioactivity determined by Cerenkov 
counting or from an aliquot by liquid scintillation 
counting in 10% (v/v) Biosolve as indicated. 
3. RESULTS AND DISCUSSION 
3.1. Tryptic derivatives of eIF-2u phosphorylated 
in the presence of spectrin 
The isolated LY- or P-subunit of erythroid spec- 
trin or certain of their large peptide derivatives 
cause an increase in the extent of eIF-ti 
phosphorylation by the reticulocyte heme- 
controlled kinase (Kudlicki et al., submitted). In 
the experiments described in figs 1 and 2 eIF-2 was 
extensively phosphorylated by this enzyme in the 
presence of cu-spectrin. The phosphorylated eIF-h 
subunit was isolated, subjected to tryptic digestion 
for 20 min and the tryptic phosphopeptides re- 
solved by HPLC. Two major phosphopeptide 
peaks were observed, one corresponding to the 
previously defined T-44 peptide [2]. The second 
peak which eluted at 39% acetonitrile (termed 
T-39; fig.1) was relatively diminished when 
phosphorylation was carried out in the absence of 
17 
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spectrin (fig. 1, inset). The T-39 peptide was deter- 
mined to have the same NHz-terminal sequence as 
the T-44 peptide (residues identified Ser-Ile-Ala- 
Glu-Met-Gly-Ala-Tyr-Val-Ser-Leu-Leu) which 
suggests the possibility that T-39 might represent 
an extended or more extensively phosphorylated 
form of the T-44 sequence. 
3.2. Identification of Ser 51 of eZF-2cu as a 
phosphorylation site for the reticulocyte 
heme-controlled kinase 
To investigate further the phosphorylation 
status of Ser 48 and 51 in the T-44 and T-39 se- 
quences, subdigestion with protease Vs from 
Staphylococcus aureus was performed. A potential 
cleavage site for VS protease occurs within the T-44 
peptide at Glu 49 that would separate Ser 48 and 
Ser 51. Both T-39 and T-44 were subdigested 
separately with VS protease and the resulting 
phosphopeptides were analyzed by HPLC. The VS 
digest of the T-39 peptide contained two 
phosphopeptides that eluted at about 44 and 9% 
acetonitrile, termed the V-44 and V-9 peptides, 
respectively, with little radioactivity eluting at ‘the 
T-39 position (fig.2A). The amino acid sequence of 
the V-9 peptide was determined to be Leu-Ser-Arg, 
which corresponds to the eIF-2&O-52) sequence 
and includes Ser 51, which thus appears to have 
been phosphorylated in the original T-39 peptide. 
VS protease digestion of the T-44 peptide generates 
one prominent phosphopeptide luting in a posi- 
tion similar to that of V-44 and only a trace of V-9 
(fig.2B). This suggests that the T-44 peptide was 
not phosphorylated appreciably at Ser 5 1. 
The V-44 phosphopeptides were subjected to ex- 
haustive trypsin digestion and reanalyzed by 
HPLC. A major phosphopeptide luting.at 16% 
acetonitrile (T-16) was detected together with a 
trace amount of the later eluting T-26 derivative [2] 
that would have been generated from any 
T-44/T-39 peptides undigested by the VS protease 
(not shown). The NHz-terminal sequence of the 
T-16 peptide was determined to be Ile-Leu-Leu- 
Ser... corresponding to the sequences of eIF-2cu 
from Ile 45 to Ser 48 and presumably terminating 
at Glu 49, thus confirming that Ser 48 is also a 
phosphorylation site, as reported earlier [2]. Con- 
sidered together these results suggest that the T-39 
peptide differs from T-44 in that it is 
phosphorylated at both Ser 48 and Ser 5 1, whereas 
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Fig. 1. Tryptic phosphopeptides generated from 
phosphorylated eIF-h. Phosphorylation of eIF-2 was 
carried out by the reticulocyte heme-regulated kinase in 
the presence of cu-spectrin using [Y-~~P]ATP as described 
in section 2. The phosphorylated a-subunit of eIF-2 was 
separated from the fl- and y-subunits and unphosphory- 
lated a-subunit by HPLC as described in 121. About 
30 pg phosphorylated eIF-2cY was incubated with 5 cg 
trypsin for 20 min as in [2], then the resulting peptides 
were separated by HPLC using a reversed-phase Cs 
column. Radioactivity of the resulting fractions was 
determined by Cerenkov counting. Inset: tryptic 
phosphopeptides obtained under similar conditions 
except hat the phosphorylation reaction was carried out 
in the absence of cu-spectrin (cf. [2]). 
the T-44 peptide appears to be phosphorylated 
predominantly at Ser 48. 
Most of the phosphopeptides evident in fig.1 
were tryptic variants containing the Ser 48/Ser 51 
sites. However, analysis of a minor phosphopep- 
tide fraction eluting at -15% acetonitrile, which 
was more apparent in 12 h digests and was variable 
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Fig.2. Va peptides generated from the T-39 and T-44 
tryptic phosphopeptides of eIF-2cu. The T-44 and T-39 
tryptic peptides (see fig. 1) were digested separately with 
Vs protease under the conditions given in section 2. The 
resulting peptides were fractionated by HPLC and 
radioactivity determined as described for fig. 1. (A) VS 
peptides derived from T-39 after 3.5 h incubation. (B) 
V8 peptides derived from T-44 after 10 h incubation. 
in amount (not shown), gave the sequence 
Leu Thr Val Ser. A sequence Thr-Val-Tyr-Ser is found as 
amino acids 106-109 in both rat and human 
eIF-h [3], whereas Ser-Val-Leu-Ser occurs in 
human eIF-2cr only at positions 248-25 1 [3]. It is 
not clear which amino acids in these sequences are 
phosphorylated. However, they present the 
possibility of additional phosphorylation sites in 
eIF-2cu not restricted to the amino-terminal se- 
quence and possibly involving phosphorylation by 
another contaminating kinase. 
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Fig.3. Phosphorylated synthetic eIF-2cu(41-54) corre- 
sponding to the eIF-2Lu sequence from Be 41 to Arg 54. 
The synthetic peptide was phosphorylated with [y- 
32P]ATP by the eIF-2ru kinase as described in section 2, 
then analyzed by HPLC as described in fig. 1. (A) HPLC 
of the phosphorylation reaction mixture (see text). A 
large radioactive peak of ATP at 0% acetonitrile is not 
shown. Fractions were collected after the onset of the 
gradient and their radioactivity determined by liquid 
scintillation counting from a 50 pl aliquot. (B) HPLC of 
Vs digest of the phosphorylated synthetic peptide. 
Fractions from A containing the phosphopeptide were 
pooled, taken to dryness, and then the peptide was 
digested with VS protease as described in section 2 and 
analyzed. Radioactivity was determined as in A with 
25~1 aliquots of the resulting fractions. 
3.3. Phosphoryiation of a synthetic peptide 
containing the eIF-2cr phosphorylation sites 
A peptide corresponding to the amino acid se- 
quence of eIF-%x(41-54) which includes the Ser 48 
and Ser 51 phosphorylation sites has been syn- 
19 
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the&&. T?p, mm& mc; ~>~~Y&&‘&! @- t& 
eIIE-ti kinase with a -&, oI-sU,&X The specirrc ac- 
tivity of the enzyme with this substrate was deter- 
mined to be approx. 5 nmol phosphate incorpo- 
rated/min per mg protein. The phosphorylated 
peptide eluted as a single radioactive peak from a 
reversed-phase HPLC column at 24% acetonitrile 
(fig.3A). Digestion of this peptide with VS protease 
foIlowed by HPLC am&is gave a single sym- 
rnetihdnfia,&&&i77 ~&&7&f!&&&&&& 
11% acetonitrile (fig.3B). The amino acid se- 
quence of this peptide was determined to be Leu- 
Ser-Arg-Arg-Arg, corresponding to the eIF-2cu se- 
quence around Ser 51. This must have been the 
only site phosphorylated since there is no indica- 
tion in the elution profile of a phosphopeptide con- 
taining Ser 4%. Recuvm of radiuaclivity was over 
90%. Including a-spectrin in the phosphorylation 
reaction did not affect the results presented in 
fig.3. ‘No phospnory~a~rm o’iSnt 6% was &smY& 
under these conditions. Apparently, in the syn- 
thetic peptide corresponding to eIF-2cu(41-54) Ser 
51 is the only phosphorylation site for the heme- 
ccntrolled elF-2cu kinase. Thus features of elF-2cr 
be&& its viaa~j sqsw< fqaa ~a<qti && 41 
to 54 must convert Ser 48 to a predominant 
phosphorylation site for the heme-controlled 
eIF-ti kinase. 
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